Fighting colorectal cancer alongside patient advocacy and
Springfield, Missouri, July 20. 2022 (GLOBE NEWSWIRE) — Earlier this year, President Joe Biden announced plans to relaunch the Cancer Moonshot with renewed leadership and ambitious new goals to “end cancer as we know it.” As part of this effort, the President and First Lady Jill Biden issued a call to action to prioritize advances in cancer screening and to ensure that all Americans benefit from advances in cancer prevention. . In response, the national nonprofit advocacy organization Fight Colorectal Cancer (Fight CRC) has brought together a group of colorectal cancer (CRC) patient advocates and business leaders to respond to this call. . On July 25, 2022, the White House will host Fight CRC and this group to discuss ways all stakeholders can work together to improve and increase access to CRC testing.
These business and patient advocacy leaders choose to come together to support efforts that demonstrate their shared commitment to help increase access to CRC screening for all Americans. The group will explore both policy solutions and ideas for public-private partnerships that will help achieve the president’s Cancer Moonshot goals.
The challenge is clear: in the United States, only 69% of adults aged 50 to 75 are up to date with CRC screening, and in qualified federal health centers, the largest providers of care for the underinsured and uninsured, only 44% of the population is up to date. The decline in colorectal cancer screenings has been exacerbated by the COVID-19 pandemic. A 2020 analysis by Komodo Health and Fight CRC found that the total number of colonoscopies and biopsies decreased by nearly 90% in April 2020 compared to the same period in 2019. Despite the availability of several safe screening options and effective work of the CCR, the CRC remains number one. 2 overall cancer killer for men and women combined, with communities of color seeing even higher incidence and mortality rates.
“This is the first time a group like this has come together to align with a common goal,” said Anjee Davis, President of Fight CRC. “This working group is a response to a ‘moonshot’. The challenges facing CRC screening and prevention can seem overwhelming. But this group has the opportunity to go beyond incremental change. I believe we can strive to make sweeping changes to bring testing and care to every community in our country.
Attendees at the White House meeting:
Carolyn “Bo” Aldigé – Cancer Prevention Foundation, Founder
Alexey Aleshin, MD, MBA – Natera, Managing Director, Early Cancer Detection
Andrew Barnell, MBA – Geneoscopy Inc., CEO and Co-Founder
Danielle Carnival, PhD – White House Cancer Moonshot, Coordinator
Austin Chiang, MD, MPH – Medtronic, gastrointestinal CMO
Kevin Conroy – Exact Sciences, President and CEO
Erin Darbouze, MPH – Colorectal Cancer Control, Health Policy Manager
Anjee Davis, MPPA – Colorectal Cancer Control, Chair
Richard Goldberg, MD – Colorectal Cancer Control, Board Member
Greg Hamilton, MBA – Epigenomics, CEO
Lisa Lacasse, MBA – American Cancer Society Cancer Action Network (ACS CAN), President
David Lieberman, MD, AGAF – American Association of Gastroenterology, Past President
Molly McDonnell – Colorectal Cancer Control, Advocacy Director
Arif Nathoo, MD, MPA – Komodo Health, Co-Founder and CEO
Angela Nicholas, MD – Colorectal Cancer Control, Board Chair
Mike Nolan, MBA – Freenome, CEO
AmirAli Talasaz, PhD – Guardant Health, co-founder and co-CEO
Catharine Young, PhD – Associate Director for Cancer Moonshot Engagement and Policy
“This group is dreaming big about how a public-private partnership can reach everyone, from prevention to treatment,” Davis said. “There are still 44 million people who need to be screened.”